首页> 外国专利> Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex

Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex

机译:三聚体Hiv-1包膜糖蛋白复合物产生的Hiv-1中和抗体

摘要

This invention provides methods for eliciting an immune response in a subject comprising administering to the subject as part of a regimen (i) more than one dose of a nucleic acid prime, and (ii) more than one dose of a protein boost composition, wherein each dose of the nucleic acid prime is administered to the subject at a first predefined interval and each dose of the protein boost composition is administered to the subject at a second predefined interval, and wherein the protein boost composition comprises a prophylactically or therapeutically effective dose of (a) a trimeric HIV-1 gp140 protein complex, or (b) a superparamagnetic particle and a trimeric HIV-1 gp140 protein complex so affixed thereto as to permit recognition of the complex by a subject's immune system. The invention also provides methods for prophylactically or therapeutically treating HIV-1 infection in a subject. The invention further provides uses of a nucleic acid prime and a protein boost composition for the manufacture of separate coadministerable medicaments to be administered to a subject.
机译:本发明提供了在受试者中引发免疫应答的方法,该方法包括作为方案的一部分对受试者给药(i)多于一剂的核酸初免,和(ii)多于一剂的蛋白质增强组合物,其中以第一预定间隔向受试者施用每一剂量的核酸初免,并且以第二预定间隔向受试者施用每一剂量的蛋白质增强组合物,并且其中蛋白质增强组合物包含预防或治疗有效剂量的(a)三聚体HIV-1 gp140蛋白复合物,或(b)超顺磁性颗粒和三聚体HIV-1 gp140蛋白复合物,其如此附着以允许受试者的免疫系统识别该复合物。本发明还提供了预防或治疗对象的HIV-1感染的方法。本发明进一步提供了核酸引物和蛋白质增强组合物在制备要施用于受试者的单独的可共同施用的药物中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号